The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. (Q38267478)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

The role of leptin/adiponectin ratio in metabolic syndrome and diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Patricio López-Jaramillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jose López-López

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Cristina López-López

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Javier Martínez-Ortega

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Andrea Gómez-Rodríguez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Stefany Triana-Cubillos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

1 reference

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

Hormone Molecular Biology and Clinical Investigation

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

37-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389999%20AND%20SRC:MED&resulttype=core&format=json

Adiponectin: more than just another fat cell hormone?

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Clinical review: adiponectin biology and its role in inflammation and critical illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adiponectin and future coronary heart disease events among men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adiponectin, obesity, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Obesity: the hormonal milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Ethnic differences in adiponectin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Inflammation and hypertension: are there regional differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

The ratio of leptin to adiponectin can be used as an index of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Blockade of the RAS increases plasma adiponectin in subjects with metabolic syndrome and enhances differentiation and adiponectin expression of human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Reduction in acute myocardial infarction mortality over a five-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Blockade of endothelial enzymes: new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

The insulin resistance syndrome: definition and dietary approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Impact of the renin-angiotensin system on lipid and carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adiponectin as a biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Chronic inflammation in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053

Plasma Leptin Levels Are Associated with Coronary Atherosclerosis in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2013-0053